The top predicted CNV regions associated with risk included FGFR1OP2 (RR=0.20, P=5 × 10−4) and PABPC4L (RR=0.22, P=0.006) for breast and ovarian cancer, respectively. The gene discussed is PABPC4L; the disease is ovarian carcinoma.